Combining Interpersonal Therapy with Brain Stimulation for Teen Depression
Official title: Effects of Augmentation of Interpersonal Psychotherapy With High-Definition Transcranial Direct Current Stimulation for Adolescent Depression: A Randomized Clinical Trial
Run by First Affiliated Hospital of Zhejiang University · NCT06061653 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if adding brain stimulation to talk therapy can help teenagers with depression feel better compared to just talk therapy alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 18 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | First Affiliated Hospital of Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06061653 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are right-handed adolescents aged 12 to 18 of Han ethnicity who are experiencing their first episode of depression or a relapse and have not received prior treatment.
✕Probably not a fit
Patients with metal implants, certain medical conditions, or those who have previously received treatment for depression may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of augmenting interpersonal psychotherapy (IPT) with high-definition transcranial direct current stimulation (HD-tDCS) in treating adolescent depression. It targets adolescents aged 12 to 18 who meet the DSM-5 criteria for depression and have either their first episode or a relapse of depression. Participants will be randomly assigned to receive either IPT with HD-tDCS or IPT with sham stimulation, allowing researchers to compare the outcomes of both approaches. The study aims to address the unique challenges of treating depression in adolescents, particularly given the limitations of current pharmacological options.
Why it matters
Potential benefit: If successful, this approach could provide a safer and more effective treatment option for adolescents suffering from depression.
How similar studies have gone: While the combination of IPT and HD-tDCS is a novel approach, previous studies have shown promising results for both IPT and tDCS in treating depression.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Sign a written informed consent form, willing to participate in the study and accept treatment (patients under 18 years of age need to obtain the consent of their parents or legal guardians); 2. Age between 12 and 18 years; 3. Right-handed; 4. Han ethnicity; 5. Meet the DSM-5 diagnostic criteria for depression; 6. HAMD-24≥20; 7. Understand written language and able to complete questionnaires; 8. First-episode depression patients who have never received any treatment or relapse depression patients, have not taken any psychotropic drugs in the past 2 weeks, have not received systematic psychological or physical therapy. Exclusion Criteria: 1. Exclusion criteria for tDCS: (1) Patients with metal implants in the body; those with metal implants such as titanium or magnetic devices (including aneurysm clips); (2) Patients with implanted devices such as cardiac pacemakers, deep brain stimulators (DBS); (3) Patients with intracranial hypertension, skull defects, or tumors; (4) Patients with unstable vital signs such as severe cardiac or somatic diseases; (5) Patients in the acute phase of cerebrovascular diseases; (6) Patients with adverse reactions to electrical stimulation; (7) Patients with pain sensitivity, injury, or inflammation in the stimulation area. 2. Exclusion criteria for MRI; 3. Patients with severe neurological, cardiac, liver, kidney, endocrine, and blood system diseases, or any other condition that may interfere with the study evaluation; 4. Patients with organic mental disorders and mental retardation; 5. Patients with alcohol or drug dependence; 6. Patients with a high risk of suicide.
Where it's running
-
The First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Manli Huang, M.D
- Email: huangmanli@zju.edu.cn
- Phone: 13957162975
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Aerobic Exercise as an Adjunct Therapy for Depression
This study tests whether adding a structured aerobic exercise program to standard antidepressant and therapy helps reduce depression severity more than standard care alone.
-
Group Unified Protocol for Emotional Disorders in adults in public mental health (UP in Spanish)
A group-based Spanish version of the Unified Protocol is being tested with adults in public mental health to see if it helps anxiety, depression, and related symptoms.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
-
Mindfulness‑augmented brain stimulation for treatment‑resistant depression
This trial will test whether combining fast brain stimulation (iTBS) with a digital mindfulness program helps people with treatment‑resistant depression reduce symptoms and improve thinking.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.